| | |
Radhieka Pandeya 01:15 AM | October 02,2009
The US drug regulator found 88 cases of acute pancreatitis in its surveillance of the diabetes drug
|
|
Radhieka Pandeya 12:25 AM | March 28,2009
India’s drugs regulator has asked Shreya for details of imports, status of any clinical post-marketing trials
|
|
Radhieka Pandeya 01:15 AM | March 18,2009
In India, Panacea’s mOPV1 and mOPV3 are procured by the government through the Unicef for its pulse polio programme
|
|
C.H. Unnikrishnan 09:25 PM | March 15,2009
This study aims at providing data on the so-called real world experience with Champix in India where the drug was launched in March 2008
|
|
Radhieka Pandeya 12:11 AM | October 02,2008
The drug price regulator collected the fines from drug makers who sold medicines in dosages not approved by it
|
|
10:40 AM | July 20,2008
A proposal has been submitted to set up offices in Mumbai, Delhi and Hyderabad in collaboration with the Drug Controller General of India (DCGI)
|
|
Bhuma Shrivastava and C.R. Sukumar 11:57 PM | January 11,2008
USFDA plans to set up regional offices, hire independent inspectors and collaborate with their counterparts in different countries for stricter implementation of safety and quality norms
|
|
C.H. Unnikrishnan 12:27 AM | December 19,2007
The court had stayed an order of DCGI that banned combination drug licences issued by state authorities
|
|
01:06 PM | November 30,2007
The DCGI invokes rare law to ask states to terminate licences; confusion reigns over Madras high court order
|
|
C.H. Unnikrishnan 12:06 AM | October 19,2007
Regulators of at least five states have asked around 800 firms to withdraw combination drugs from the market
|
|
Bhuma Shrivastava 03:19 PM | June 08,2007
The Glaxo unit sells the drug, which has been placed under the sternest warning by FDA, here as Windia
|
|